Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Huxley N"" wg kryterium: Autor


Wyświetlanie 1-43 z 43
Tytuł :
Psychosocial treatments in schizophrenia : A review of the past 20 years
Autorzy :
HUXLEY, N. A
RENDALL, M
SEDERER, L
Pokaż więcej
Temat :
Psychose
Psychosis
Psicosis
Activité professionnelle
Professional activity
Actividad profesional
Adaptation sociale
Social adjustment
Adaptación social
Aptitude sociale
Social aptitude
Aptitud social
Article synthèse
Review
Artículo síntesis
Chimiothérapie
Chemotherapy
Quimioterapia
Efficacité traitement
Treatment efficiency
Eficacia tratamiento
Homme
Human
Hombre
Neuroleptique
Neuroleptic
Neuroléptico
Psychose schizoaffective
Schizoaffective psychosis
Psicosis esquizoafectiva
Psychothérapie familiale
Family psychotherapy
Psicoterapia familiar
Psychothérapie groupe
Group psychotherapy
Psicoterapia grupal
Psychothérapie individuelle
Individual psychotherapy
Psicoterapia individual
Psychotrope
Psychotropic
Psicotropo
Réadaptation sociale
Social rehabilitation
Readaptación social
Schizophrénie
Schizophrenia
Esquizofrenia
Traitement adjuvant
Adjuvant treatment
Tratamiento adyuvante
Traitement associé
Combined treatment
Tratamiento asociado
Traitement
Treatment
Tratamiento
Sciences biologiques et medicales
Biological and medical sciences
Sciences medicales
Medical sciences
Psychopathologie. Psychiatrie
Psychopathology. Psychiatry
Thérapeutiques
Treatments
Traitements associés
Associated treatments
Psychologie. Psychanalyse. Psychiatrie
Psychology. Psychoanalysis. Psychiatry
PSYCHOPATHOLOGIE. PSYCHIATRIE
Neurology
Neurologie
Psychology, psychopathology, psychiatry
Psychologie, psychopathologie, psychiatrie
Źródło :
The Journal of nervous and mental disease. 188(4):187-201
Materiał oryginalny :
INIST-CNRS
Opis pliku :
text
Dostęp URL :
http://pascal-francis.inist.fr/vibad/index.php?action=search&terms=1354524
Czasopismo naukowe
Tytuł :
PCN157 - Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS
Autorzy :
Snowsill, T.
Pokaż więcej
Źródło :
In Value in Health November 2014 17(7):A641-A642
Czasopismo naukowe
Tytuł :
PCN22 - What is the Clinical Effectiveness and Cost- Effectiveness of Erythropoietin-Stimulating Agents for the Treatment of Patients with Cancer-Treatment Induced Anaemia? Insights from Cumulative Meta-Analyses (CMA) and Lessons for Cost-Effectiveness Analyses
Autorzy :
Huxley, N.
Haasova, M.
Crathorne, L.
Hyde, C.
Pokaż więcej
Źródło :
In Value in Health November 2014 17(7):A617-A617
Czasopismo naukowe
Tytuł :
1502P - What is the Clinical and Cost Effectiveness of Erythropoietin-Stimulating Agents for the Treatment of Patients with Cancer-Treatment Induced Anaemia? Insights from Cumulative Meta-Analyses (Cma) and Lessons for Cost-Effectiveness Analyses
Autorzy :
Haasova, M.
Crathorne, L.
Huxley, N.
Hyde, C.
Pokaż więcej
Źródło :
In Annals of Oncology September 2014 25 Supplement 4:iv525-iv525
Czasopismo naukowe
Tytuł :
1498P - What is the Clinical Effectiveness of Erythropoiesis Stimulating Agents for the Treatment of Cancer Treatment-Induced Anaemia?
Autorzy :
Crathorne, L.
Pokaż więcej
Źródło :
In Annals of Oncology September 2014 25 Supplement 4:iv523-iv523
Czasopismo naukowe
Tytuł :
1038PD - A Cost-Effectiveness Analysis of Erythropoiesis-Stimulating Agents for Treating Cancer-Treatment Induced Anaemia
Autorzy :
Huxley, N.
Pokaż więcej
Źródło :
In Annals of Oncology September 2014 25 Supplement 4:iv357-iv357
Czasopismo naukowe
Tytuł :
PCN126 - Cost-Effectiveness of Systematic Testing for Lynch Syndrome in Patients Newly Diagnosed with Colorectal Cancer in the United Kingdom
Autorzy :
Huxley, N.
Pokaż więcej
Źródło :
In Value in Health November 2013 16(7):A414-A414
Czasopismo naukowe
Tytuł :
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Autorzy :
Kang YJ; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Killen J; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Caruana M; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Simms K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Taylor N; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Frayling IM; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom.; Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom.
Snowsill T; University of Exeter Medical School, Exeter, United Kingdom.
Huxley N; Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC.
Coupe VM; Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Hughes S; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Freeman V; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Boussioutas A; University of Melbourne, Melbourne, VIC.; Royal Melbourne Hospital, Melbourne, VIC.
Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Ward RL; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Mitchell G; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Macrae FA; Royal Melbourne Hospital, Melbourne, VIC.
Canfell K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2020 Feb; Vol. 212 (2), pp. 72-81. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonoscopy/*statistics & numerical data
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Cost-Benefit Analysis/*statistics & numerical data
Genetic Testing/*economics
Aged ; Australia/epidemiology ; Colonoscopy/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/mortality ; Female ; Humans ; Immunohistochemistry/economics ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.
Autorzy :
Tikhonova IA; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK. .
Huxley N; Monash University, Melbourne, VIC, Australia.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Crathorne L; Roboleo Ltd, York, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Pokaż więcej
Źródło :
PharmacoEconomics [Pharmacoeconomics] 2018 Jul; Vol. 36 (7), pp. 837-851.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*economics
Camptothecin/*analogs & derivatives
Cetuximab/*economics
Colonic Neoplasms/*economics
Colorectal Neoplasms/*economics
Cost-Benefit Analysis/*statistics & numerical data
Panitumumab/*economics
Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Camptothecin/economics ; Camptothecin/therapeutic use ; Cetuximab/therapeutic use ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/genetics ; Colonic Neoplasms/secondary ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/secondary ; Female ; Fluorouracil/economics ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/economics ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Models, Economic ; Organoplatinum Compounds/economics ; Organoplatinum Compounds/therapeutic use ; Panitumumab/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic/statistics & numerical data ; Survival Analysis
SCR Protocol :
Folfox protocol; IFL protocol
Czasopismo naukowe
Tytuł :
A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.
Autorzy :
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK. .
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Frayling IM; Institute of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, South Cloisters, St Lukes Campus, Heavitree Road, Exeter, Devon, EX1 2LU, UK.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2017 Dec 08; Vol. 17 (1), pp. 836. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Microsatellite Instability*
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Molecular Diagnostic Techniques/*methods
Molecular Diagnostic Techniques/*standards
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Reproducibility of Results ; Young Adult
Czasopismo naukowe
Tytuł :
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Frayling IM; Institute of Cancer and Genetics, University Hospital of Wales, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Sep; Vol. 21 (51), pp. 1-238.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Genetic Testing*/economics
Genetic Testing*/methods
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; DNA Mismatch Repair ; Endometrial Neoplasms ; England ; Female ; Humans ; Microsatellite Instability ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Tikhonova I; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Jun; Vol. 21 (38), pp. 1-294.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Treatment Outcome*
Antibodies, Monoclonal/*administration & dosage
Antibodies, Monoclonal/*economics
Antineoplastic Agents/*administration & dosage
Antineoplastic Agents/*economics
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Agents, Immunological/*economics
Cetuximab/*administration & dosage
Cetuximab/*economics
Colorectal Neoplasms/*drug therapy
Neoplasm Metastasis/*drug therapy
Cost-Benefit Analysis ; Female ; Humans ; Male ; Panitumumab ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Autorzy :
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Peters J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Moore J; Exeter Kidney Unit, Royal Devon and Exeter Foundation Trust Hospital, Exeter, UK.
Allwood M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (62), pp. 1-594.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/economics ; Abatacept/therapeutic use ; Antibodies, Monoclonal ; Antilymphocyte Serum ; Basiliximab ; Bayes Theorem ; Cost-Benefit Analysis ; Everolimus/economics ; Everolimus/therapeutic use ; Graft Rejection/prevention & control ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/economics ; Mycophenolic Acid/therapeutic use ; Quality of Life ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Recombinant Fusion Proteins ; Sirolimus/economics ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Autorzy :
Haasova M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Crathorne L; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Lowe J; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Dudley J; Department of Paediatric Nephrology, Bristol Royal Hospital for Children (University Hospitals Bristol NHS Foundation Trust), Bristol, UK.
Marks S; Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Bond M; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Anderson R; Peninsula Technology Assessment Group (PenTAG), Evidence Synthesis & Modelling for Health Improvement, University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Aug; Vol. 20 (61), pp. 1-324.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Immunosuppressive Agents/*economics
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*methods
Abatacept/therapeutic use ; Antibodies, Monoclonal/economics ; Antibodies, Monoclonal/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Azathioprine/economics ; Azathioprine/therapeutic use ; Basiliximab ; Child ; Clinical Trials as Topic ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Everolimus/therapeutic use ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Models, Economic ; Mycophenolic Acid/therapeutic use ; Recombinant Fusion Proteins/economics ; Recombinant Fusion Proteins/therapeutic use ; Sirolimus/therapeutic use ; Tacrolimus/economics ; Tacrolimus/therapeutic use ; Technology Assessment, Biomedical
Czasopismo naukowe
Tytuł :
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Autorzy :
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Medina-Lara A; University of Exeter Medical School, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter Hospital, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Feb; Vol. 20 (13), pp. 1-588, v-vi.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Technology Assessment, Biomedical*
Anemia/*drug therapy
Hematinics/*therapeutic use
Neoplasms/*drug therapy
Anemia/economics ; Anemia/etiology ; Hematinics/economics ; Humans ; Models, Economic ; Neoplasms/economics ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Autorzy :
Snowsill T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Huxley N; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. n.j.huxley@exeter.ac.uk.
Hoyle M; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Jones-Hughes T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Coelho H; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Cooper C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Frayling I; Institute of Cancer & Genetics, Cardiff University, Cardiff, UK. .
Hyde C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2015 Apr 25; Vol. 15, pp. 313. Date of Electronic Publication: 2015 Apr 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Age of Onset ; Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; DNA Mutational Analysis ; Decision Making, Computer-Assisted ; Female ; Humans ; Male ; Middle Aged ; Models, Economic ; Molecular Diagnostic Techniques/economics ; Quality-Adjusted Life Years ; Risk ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Autorzy :
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Meng Y; School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Mújica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2015 Jan; Vol. 19 (2), pp. v-xxv, 1-215.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Breast Neoplasms/*pathology
Lymph Nodes/*pathology
Nucleic Acid Amplification Techniques/*methods
Axilla ; Cost-Benefit Analysis ; England ; Humans ; Intraoperative Period ; Lymphatic Metastasis ; Quality of Life ; Quality-Adjusted Life Years ; Sensitivity and Specificity ; Sentinel Lymph Node Biopsy ; State Medicine
Czasopismo naukowe
Tytuł :
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Cooper C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Frayling I; Institute of Medical Genetics, Cardiff University, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2014 Sep; Vol. 18 (58), pp. 1-406.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; Genetic Testing/economics ; Genetic Testing/methods ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł :
Disability and its treatment in bipolar disorder patients.
Autorzy :
Huxley N; The International Consortium for Bipolar Disorder Research, Department of Psychiatry, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA, USA. />Baldessarini RJ
Pokaż więcej
Źródło :
Bipolar disorders [Bipolar Disord] 2007 Feb-Mar; Vol. 9 (1-2), pp. 183-96.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Disability Evaluation*
Recovery of Function*
Bipolar Disorder/*psychology
Bipolar Disorder/*therapy
Acute Disease ; Antidepressive Agents/therapeutic use ; Antipsychotic Agents/therapeutic use ; Bipolar Disorder/epidemiology ; Cognition Disorders/epidemiology ; Combined Modality Therapy ; Humans ; Prognosis ; Psychotherapy ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence.
Autorzy :
Huxley NA; International Consortium for Bipolar Disorder Research (Drs. Huxley, Parikh, and Baldessarini).
Parikh SV
Baldessarini RJ
Pokaż więcej
Źródło :
Harvard review of psychiatry [Harv Rev Psychiatry] 2000 Sep; Vol. 8 (3), pp. 126-40.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
MeSH Terms :
Bipolar Disorder/*therapy
Bipolar Disorder/economics ; Cost-Benefit Analysis ; Humans ; Psychotherapy/economics ; Psychotherapy/methods
Czasopismo naukowe
    Wyświetlanie 1-43 z 43

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies